IZ Express

Issue 1784: November 13, 2024

Top Stories
 
Immunize.org Website and Clinical Resources
 
Vaccine Information Statements
 
Featured Resources
 
Notable Publications
 
Upcoming Events
 
Top Stories

CDC posts new COVID-19 vaccine interim clinical considerations. Immunize.org updates “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools.”

CDC posted Use of COVID-19 Vaccines in the United States: Interim Clinical Considerations on October 31, incorporating its recent changes to COVID-19 vaccine recommendations. Immunize.org's November 3 version of its Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools links to the new recommendations, as well as linking to:

  • Updated COVID-19 mRNA VIS (updated 10/17/24)
  • Translations of EUA fact sheets for recipients and caregivers (updated 10/29); these translations correspond with the August English versions of the fact sheets for Pfizer-BioNTech (age 6 months through 4 years), Moderna (age 6 months through 11 years), and Novavax (age 12 years and older)
  • Emergency Use Instructions (EUIs) for Pfizer-BioNTech and Moderna (updated 10/29)
  • MMWR index link (updated 10/31)

All COVID-19 vaccine providers should regularly review this checklist. Download the latest documents and discard outdated versions.

Related Links


Institute for Safe Medication Practices releases "2022–23 Bi-Annual Report" describing vaccination-related errors and strategies to prevent them

The Institute for Safe Medication Practices (ISMP) recently released its "2022–2023 Bi-Annual Report" from the ISMP National Vaccine Errors Reporting Program. The report demonstrates that errors continue to be problematic, with newer vaccines adding new opportunities for mistakes.

Analysis of nearly 2,000 events reported over the 2 years from January 1, 2022, through December 31, 2023, showed that the most frequent types of reported errors were:

  • Wrong vaccine (25%)
  • Expired vaccine, contamination, or deterioration (20%)
  • Wrong dose, both overdosing and underdosing events (12%)
  • Wrong age (10%)
  • Extra dose (9%)
  • Wrong time or interval (7%)
  • Vaccine or component omission, i.e., when only the diluent or a single component of two-component vaccine was administered (4%)
  • Wrong route (2%)
  • Wrong patient (1%)

ISMP’s most recent sets of best practices for hospitals and community pharmacies show how healthcare organizations can safeguard against errors with vaccines. Additional ISMP safe practice recommendations include:

  • Maximize the use of technology safeguards
  • Ensure safe storage
  • Verify identity, age, and vaccine(s) requested
  • Prepare and label syringes
  • Engage the patient
  • Document the vaccine(s)
  • Educate practitioners
  • Report vaccine-related errors

The continued success of immunization programs relies on proper prescribing, dispensing, storage, and administration of vaccines. For more information, view the 2022–2023 Bi-Annual Report.


Immunize.org updates “Measles: Questions and Answers”

Immunize.org updated its resource Measles: Questions and Answers. Updates revise rates of measles complications, data on current outbreaks, and several URLs.



Related Links


Influenza activity is low nationally; get vaccinated now before the holidays

The 2024–25 U.S. influenza season is underway and now is the time to vaccinate. For the fourth week of the 2024–25 influenza season, week 44, ending November 2, CDC’s Weekly U.S. Influenza Surveillance Report, FluView, shows low respiratory illness activity nationally.



RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for weekly reports of hospitalizations due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV.

Influenza Vaccination Dashboard
As of October 26, 2024, 28.1% of adults received a flu vaccination, similar to last year at this time. The percentage of adults who received a flu vaccination varied by age, disability status, health insurance, poverty status, race and ethnicity, sex, and urbanicity.

CDC recommends everyone age 6 months and older get annual influenza vaccination. Influenza and other vaccines (e.g., COVID-19 vaccine, RSV vaccine) may be given at the same visit, if needed. Infants age 6 months and older may receive influenza and COVID-19 vaccines at the same visit when they receive the RSV preventive antibody, nirsevimab. Identify pharmacies in your area that may offer influenza and COVID-19 vaccines by entering a zip code in the VaccineFinder on Vaccines.gov or Vacunas.gov.

Related Links


Immunize.org updates its “Vaccine History Timeline” with recent advances

Do you need to know the year that CDC made a vaccination recommendation or FDA approved a new vaccine? Refer to Immunize.org’s Vaccine History Timeline. This useful reference resource was recently updated to include new vaccine-related events.



If you would like to suggest an event to add, contact us at admin@immunize.org.


“Recommendations for the Use of Human Papillomavirus (HPV) Vaccine”: Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube

This week, our featured episode from the Ask the Experts Video Series is Recommendations for the Use of Human Papillomavirus (HPV) Vaccine. The video describes CDC’s recommended immunization schedule for routine HPV vaccination. The episode discusses the option of starting the HPV series at age 9, catch-up vaccination of young adults, and the option for vaccination of previously unvaccinated adults ages 27 through 45 years.

The 2-minute video is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions.

Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.


Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.


Immunize.org Website and Clinical Resources

Spotlight on the website: "Travel Vaccines" main page

This week’s Spotlight features our recently launched Travel Vaccines main page that makes it easy to access current travel vaccination guidance from authoritative sources. Found under the Vaccines & VISs tab, this section links to key travel vaccination resources from CDC and other nongovernmental experts, such as the World Health Organization. Direct links to popular resources in the CDC Travelers’ Health website and the current CDC Yellow Book make it easy to locate what you and traveling patients need.

Scroll down this main page to see a disease directory that lists preventable diseases with travel vaccination considerations. Links take you directly to the new travel information section of vaccine-specific Vaccine A–Z pages on our website.


Recap: Immunize.org updates eight patient handouts promoting vaccinations for adults

Immunize.org recently updated its series of one-page vaccination guides for adults generally, men who have sex with men, and adults with any of six chronic health conditions. Where relevant, guides now also incorporate the latest recommendations for:

  • Adults who may need mpox vaccine
  • Pneumococcal conjugate vaccine (PCV) for all adults age 50 and older
The revised handouts for adults are listed below.

Related Links


Summary: These updated Immunize.org clinical resources were released during September and October

IZ Express regularly provides readers with information about Immunize.org’s new and updated web pages, educational materials for healthcare professionals, and patient handouts. All Immunize.org clinical resources are free to distribute.

Immunize.org Updated Materials for Clinicians

Web Pages
Vaccine Information Statements

Summary: VISs and VIS-related resources released in October

IZ Express provides readers with information about new and updated VISs, translations, and resources.

On October 17, 2024, CDC released three updated VISs:

As a result of these VIS releases, two clinical resources related to VISs were updated: Immunize.org created two new clinical resources that link to VISs via QR codes: Another recent resource provides QR code links directly to 44 translations of the influenza-inactivated or recombinant VIS.

All these resources appear on our new Clinical Resources A–Z Topic: VIS-Related Resources.


Featured Resources

American Academy of Pediatrics develops discussion guides and infographics for maternal and infant, childhood, and adolescent vaccines

The American Academy of Pediatrics (AAP) developed vaccine discussion guides that pair with infographics. The guides are typically one page long and describe background on the infection, how it spreads, why families should vaccinate, options for vaccinations, and more. These can be paired with an infographic when talking with the family.

The three immunization discussion guides include:



View the AAP communication aids.


Public Health Foundation creates video series for healthcare professionals and community workers to address vaccination barriers

The Public Health Foundation (PHF), partnering with Wellness Equity Alliance, developed a four-part pediatric vaccination video series for healthcare professionals and community health workers. This video series is designed to improve pediatric vaccination rates, reduce vaccine hesitancy among parents and caregivers, and promote equitable healthcare access and workforce development. The series includes:

  • Module 1: “Communicating about Pediatric Vaccines”
  • Module 2: “Health Equity in Pediatric Vaccination”
  • Module 3: “Activating Trusted Partners in Pediatric Vaccination”
  • Module 4: “Broadening and Optimizing Pediatric Vaccine Access”



View the video series.


American Academy of Pediatrics launches free immersive simulation to teach providers how to have more effective immunization conversations

The American Academy of Pediatrics, partnering with Bodyswaps, launched a free, 30-minute immersive learning simulation titled Increasing Immunization Confidence to help pediatricians and their team members hold more effective immunization conversations. In this interactive learning module, participants join a virtual pediatric clinic and engage in immunization scenarios with parents who are hesitant about vaccinating their children.

With virtual coaching that follows and adapts to your progress, participants will increase their understanding of:

  • Establishing a culture that promotes immunization confidence
  • Opening the conversation with a strong recommendation using the presumptive format
  • Responding with empathy to concerns about immunization using motivational interviewing
  • Tailoring communication to different individuals and situations



View the training course.


Children’s Hospital of Philadelphia shares new RSV resources, updated vaccine safety booklets, and a new website section on vaccine ingredients

The Children’s Hospital of Philadelphia (CHOP) Vaccine Education Center (VEC) released two new RSV Question & Answer sheets:



View VEC's Vaccine- and Vaccine Safety-Related Q&A Sheets main page for more sheets. Each can be downloaded for distribution at no charge or ordered as preprinted pads.

The Vaccine Education Center also recently updated (and retitled) its vaccine safety booklet, Vaccine Safety and Your Family; Separating Fact from Fiction (also available in Spanish). The booklet is excerpted from a recently released book published by Columbia University Press, Vaccines and Your Family; Separating Fact from Fiction. The booklet contains a code for a 30% discount on the complete book (various prices depending on format).



Order the booklet online or in printable form.

VEC website content on vaccine ingredients now includes a section titled Ingredients by Vaccine. This new section shows the vaccines and organizes the ingredients by antigen, adjuvant, stabilizers, preservatives, and residual by-products. Currently, the section includes routinely recommended vaccines for children and adults but not combination or nonroutine vaccines. These categories will be added over time.

View VEC's Ingredients by Vaccine main page.


Mighty handy! Immunize.org offers adult and lifetime handheld immunization record cards you can provide your patients.

Immunize.org's personal immunization record cards, printed on rip-proof, smudge-proof, waterproof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for providers to give to patients as a permanent personal vaccination record and are sold in boxes of 250.

Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email admininfo@immunize.org.

Related Links

Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email admininfo@immunize.org.

Related Links


Notable Publications

"Trust in the Science Behind COVID-19 Vaccines as a Driver of Vaccine Acceptance in the United States, 2021–2023" published in Vaccine X

In the December 2024 issue, Vaccine X published Trust in the Science Behind COVID-19 Vaccines as a Driver of Vaccine Acceptance in the United States, 2021–2023. Demographic variables were correlated with survey results. The results section of the abstract appears below.

The results indicate that trust in science remained relatively stable over the study period and continued to be a strong predictor of vaccine acceptance, which was higher among male respondents, those with university degrees, and those with higher than median income. Notably, the experience of personal loss was significantly related to an individual’s trust in science and vaccine acceptance.


Upcoming Events

Virtual: Questions about our website? Register for the next Immunize.org Website Office Hours on November 13 at 4:00 p.m. (ET) or November 14 at 12:00 p.m. (ET).

To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, November 13 at 4:00 p.m. (ET) or Thursday, November 14 at 12:00 p.m. (ET). The same content will be covered in both sessions.

We will open each 45-minute session with a short, live demonstration on navigating the Vaccines A–Z website section and address questions submitted in advance. You can submit questions when you register or live on Zoom during the session.

Register today for Immunize.org Website Office Hours (content is the same for both):

Mark your calendar for future Immunize.org Website Office Hours. We will hold our next pair of sessions in December.


Today! Virtual: Voices for Vaccines hosts webinar "How to Talk Vaccines Without Ruining the Holidays" on November 13 at 7:00 p.m. (ET).

Voices for Vaccines' yearly Vax Ambassador meeting, How to Talk Vaccines Without Ruining the Holidays, offers ways to engage with others about vaccines without starting a food fight. The meeting will take place at 7:00 p.m. (ET) on November 13.

Register for the webinar.


Virtual: Georgetown's O’Neill Institute offers webinar “Pandemic Influenza Vaccines: Responding to the H5 Outbreak and Preparing for the Future” on November 15 at 8:30 a.m. (ET)

O’Neill Institute for National and Global Health Law at Georgetown Law School will host a webinar titled Pandemic Influenza Vaccines: Responding to the H5 Outbreak and Preparing for the Future, at 8:30 a.m. to 12:00 p.m. (ET) on November 15. Experts, including Immunize.org's CEO, Kelly Moore, MD, MPH, will break down the current state of influenza A/H5 vaccines, their potential to prevent the next pandemic, and what must be done to bolster global preparedness.



Register for the webinar.


Virtual: North Dakota State University hosts webinar titled “New Technology, Old Fears: A Walk Through the Science and Myths of mRNA Vaccines” on November 20 at 1:00 p.m. (ET)

North Dakota State University's Center for Immunization Research and Education (CIRE) will host a webinar titled New Technology, Old Fears: A Walk Through the Science and Myths of mRNA Vaccines, 1:00–2:00 p.m. (ET) on November 20. During the webinar, participants will learn the science of how mRNA vaccines work, how they are made, the breakthroughs that made these vaccines possible, and the common myths surrounding COVID-19 mRNA vaccines. The speaker is Dan Wilson, PhD, a senior associate scientist at a biotech company who spends part of his free time exercising his passion for science communication on his YouTube channel, Debunk the Funk with Dr. Wilson.

Free pediatric maintenance of certification (MOC) credit is available for this activity.

Register for the webinar.



CIRE offers free access to recordings of its monthly webinars on its website. Participants who watch the full recording and complete the pre- and post-training quizzes may earn free CE credit for each webinar.

Learn more about CE opportunities.


For more upcoming events, visit our Calendar of Events.

About IZ Express

IZ Express is supported in part by Grant No. NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .